TickerFacts.

A business in context

CYTK research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-09-01 · 0001061983-26-000091

  2. 4 · Ownership change

    Report date 2026-08-31 · 0001061983-26-000090

  3. 4 · Ownership change

    Report date 2026-08-31 · 0001061983-26-000089

  4. 8-K · Current report

    Report date 2026-08-28 · 0001193125-26-372456 · Items 8.01,9.01

  5. 4 · Ownership change

    Report date 2026-08-18 · 0001061983-26-000088

  6. 8-K · Current report

    Report date 2026-08-13 · 0001193125-26-348060 · Items 8.01

  7. 4 · Ownership change

    Report date 2026-08-10 · 0001061983-26-000087

  8. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-338217

  9. 8-K · Current report

    Report date 2026-08-06 · 0001193125-26-338021 · Items 2.02,9.01

  10. 4 · Ownership change

    Report date 2026-07-30 · 0001061983-26-000086

  11. 4 · Ownership change

    Report date 2026-07-27 · 0001061983-26-000085

  12. 4 · Ownership change

    Report date 2026-07-21 · 0001061983-26-000084

  13. 8-K · Current report

    Report date 2026-05-27 · 0001193125-26-241840 · Items 5.07

  14. 8-K · Current report

    Report date 2026-05-06 · 0001193125-26-214606 · Items 8.01,9.01

  15. 8-K · Current report

    Report date 2026-05-05 · 0001193125-26-206420 · Items 8.01,9.01

  16. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-206364

  17. 8-K · Current report

    Report date 2026-05-05 · 0001193125-26-206360 · Items 2.02,9.01

  18. DEF 14A · Proxy statement

    Report date 2026-05-27 · 0001140361-26-015364

  19. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-076495

  20. 8-K · Current report

    Report date 2026-02-24 · 0001193125-26-067012 · Items 2.02,9.01

  21. 8-K · Current report

    Report date 2026-02-17 · 0001193125-26-053049 · Items 8.01

  22. 8-K · Current report

    Report date 2025-12-19 · 0001193125-25-326778 · Items 8.01

  23. 8-K · Current report

    Report date 2025-12-12 · 0001193125-25-316904 · Items 8.01

  24. 8-K · Current report

    Report date 2025-11-13 · 0001193125-25-282889 · Items 5.02

  25. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-267059

  26. 8-K · Current report

    Report date 2025-11-05 · 0001193125-25-266842 · Items 2.02,9.01

  27. 8-K · Current report

    Report date 2025-09-16 · 0001193125-25-209437 · Items 1.01,2.03,3.02,8.01,9.01

  28. 8-K · Current report

    Report date 2025-09-15 · 0001193125-25-204991 · Items 8.01

  29. 8-K/A · Current report

    Report date 2025-08-31 · 0000950170-25-113599 · Items 8.01,9.01

  30. 8-K · Current report

    Report date 2025-08-31 · 0000950170-25-112570 · Items 8.01,9.01

  31. 8-K · Current report

    Report date 2025-08-30 · 0000950170-25-112564 · Items 8.01,9.01

  32. 8-K · Current report

    Report date 2025-08-19 · 0000950170-25-110368 · Items 5.02

  33. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-105108

  34. 8-K · Current report

    Report date 2025-08-07 · 0000950170-25-104962 · Items 2.02,9.01

  35. 8-K · Current report

    Report date 2025-05-14 · 0000950170-25-072965 · Items 5.07

  36. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-064529

  37. 8-K · Current report

    Report date 2025-05-06 · 0000950170-25-064432 · Items 2.02,9.01

  38. 8-K · Current report

    Report date 2025-04-29 · 0000950170-25-061847 · Items 8.01

  39. DEF 14A · Proxy statement

    Report date 2025-05-14 · 0001140361-25-013167

  40. 8-K · Current report

    Report date 2025-03-10 · 0000950170-25-035914 · Items 7.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 25 transaction rows25SGrant / award: 24 transaction rows24AExercise / conversion: 50 transaction rows50MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

99 matching transaction rows. Showing 51–99.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-05-27
2026-05-27
PARSHALL B LYNNEA · Grant / award
Acquired
Non-Qualified Stock Option (Right to Buy)
Derivative security
4301.00.0
2026-05-27
2026-05-27
Landry Robert EA · Grant / award
Acquired
Common Stock2851.00.0
2026-05-27
2026-05-27
Landry Robert EA · Grant / award
Acquired
Non-Qualified Stock Option (Right to Buy)
Derivative security
4301.00.0
2026-05-27
2026-05-27
WIERENGA WENDELLA · Grant / award
Acquired
Common Stock2851.00.0
2026-05-27
2026-05-27
WIERENGA WENDELLA · Grant / award
Acquired
Non-Qualified Stock Option (Right to Buy)
Derivative security
4301.00.0
2026-05-27
2026-05-27
Wysenski NancyA · Grant / award
Acquired
Common Stock2851.00.0
2026-05-27
2026-05-27
Wysenski NancyA · Grant / award
Acquired
Non-Qualified Stock Option (Right to Buy)
Derivative security
4301.00.0
2026-05-19
2026-05-20
Malik Fady Ibraham
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock3500.07.8
2026-05-19
2026-05-20
Malik Fady Ibraham
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock3500.075.69
2026-05-19
2026-05-20
Malik Fady Ibraham
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Non-Qualified Stock Option (Right to Buy)
Derivative security
3500.00.0
2026-05-14
2026-05-14
Blum Robert I
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock7500.077.92
2026-05-05
2026-05-05
Malik Fady Ibraham
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock3500.07.8
2026-05-05
2026-05-05
Malik Fady Ibraham
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock3500.077.37
2026-05-05
2026-05-05
Malik Fady Ibraham
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Non-Qualified Stock Option (Right to Buy)
Derivative security
3500.00.0
2026-05-05
2026-05-05
WIERENGA WENDELL
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock4032.012.4
2026-05-05
2026-05-05
WIERENGA WENDELL
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock4032.075.0
2026-05-05
2026-05-05
WIERENGA WENDELL
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Non-Qualified Stock Option (Right to Buy)
Derivative security
4032.00.0
2026-05-05
2026-05-05
Lee Sung
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock23906.076.87
2026-05-05
2026-05-05
HENDERSON JOHN T
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock20000.075.97
2026-05-05
2026-05-05
HENDERSON JOHN T
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock20000.07.61
2026-05-05
2026-05-05
HENDERSON JOHN T
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Non-Qualified Stock Option (Right to Buy)
Derivative security
20000.00.0
2026-05-05
2026-05-05
Callos Andrew
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock11333.039.13
2026-05-05
2026-05-05
Callos Andrew
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock11333.077.25
2026-05-05
2026-05-05
Callos Andrew
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Non-Qualified Stock Option (Right to Buy)
Derivative security
11333.00.0
2026-05-01
2026-05-04
Callos Andrew
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock15857.037.63
2026-05-01
2026-05-04
Callos Andrew
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock15857.065.0
2026-05-01
2026-05-04
Callos Andrew
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Non-Qualified Stock Option (Right to Buy)
Derivative security
15857.00.0
2026-04-30
2026-04-30
Callos Andrew
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock15000.023.26
2026-04-30
2026-04-30
Callos Andrew
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock15000.063.26
2026-04-30
2026-04-30
Callos Andrew
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Non-Qualified Stock Option (Right to Buy)
Derivative security
15000.00.0
2026-04-29
2026-04-29
Blum Robert I
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock7500.059.62
2026-04-21
2026-04-21
Malik Fady Ibraham
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock3500.065.69
2026-04-21
2026-04-21
Malik Fady Ibraham
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock3500.07.8
2026-04-21
2026-04-21
Malik Fady Ibraham
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Non-Qualified Stock Option (Right to Buy)
Derivative security
3500.00.0
2026-04-15
2026-04-15
Wysenski NancyA · Grant / award
Acquired
Common Stock95.065.37
2026-04-15
2026-04-15
WIERENGA WENDELLA · Grant / award
Acquired
Common Stock95.065.37
2026-04-15
2026-04-15
Kaye Edward M. MDA · Grant / award
Acquired
Common Stock191.065.37
2026-04-15
2026-04-15
HENDERSON JOHN TA · Grant / award
Acquired
Common Stock325.065.37
2026-04-15
2026-04-15
Harrington Robert ArthurA · Grant / award
Acquired
Common Stock191.065.37
2026-04-15
2026-04-15
Daly James MA · Grant / award
Acquired
Common Stock191.065.37
2026-04-15
2026-04-15
Callos Andrew
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock7449.066.02
2026-04-15
2026-04-15
Blum Robert I
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock7500.065.38
2026-04-07
2026-04-08
Malik Fady Ibraham
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock3500.07.8
2026-04-07
2026-04-08
Malik Fady Ibraham
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1000.064.75
2026-04-07
2026-04-08
Malik Fady Ibraham
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock1000.010.6
2026-04-07
2026-04-08
Malik Fady Ibraham
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock3500.065.21
2026-04-07
2026-04-08
Malik Fady Ibraham
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Non-Qualified Stock Option (Right to Buy)
Derivative security
1000.00.0
2026-04-07
2026-04-08
Malik Fady Ibraham
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Non-Qualified Stock Option (Right to Buy)
Derivative security
3500.00.0
2026-04-01
2026-04-01
Blum Robert I
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock7500.066.63

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001061983CYTOKINETICS INC

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Cytokinetics · alias · wikidata
  • Cytokinetics (United States) · alias · wikidata
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$18.47M$19.66M
2023-12-31$7.53M$8.25M
2022-12-31$94.59M$107.91M
2021-12-31$70.43M$86.77M
2020-12-31$55.83M$72.03M
2019-12-31$26.87M$35.09M
2018-12-31$31.50M$41.89M
2017-12-31$13.37M$18.21M

Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

Explore the CPI history ↗